GERMS MDPI

GERMS MDPI International peer-reviewed journal on infectious diseases in humans, published by MDPI.

Germs (ISSN 2248-2997) is an international, peer-reviewed journal dedicated to advancing knowledge and understanding in the field of infectious diseases in humans at the highest standards. The journal provides a platform for the dissemination of high-quality research, clinical insights, and public health perspectives that address the prevention, diagnosis, management, and control of infectious dis

eases worldwide. Germs publishes articles on a wide range of topics, describing research results in all areas connected to infectious diseases, including, but not limited to:

• Infectious diseases across clinical and public health domains
• Epidemiology of communicable diseases
• Clinical microbiology and applied virology
• Infection prevention and control
• Antimicrobial resistance and stewardship
• Vaccinology and immunization
• Diagnostics and biomarkers in infectious diseases
• Host–pathogen interactions and immunity
• Emerging and re-emerging pathogens
• Global health, One Health, and socio-economic determinants of infections
• Public health preparedness and outbreak response
• Policy, health systems, and ethics in infectious diseases

🦠 New   Published!"Decoding   Biology: Insights into  , Structural Dynamics, Host Interactions, and  "Read here: 👉 https...
26/05/2026

🦠 New Published!

"Decoding Biology: Insights into , Structural Dynamics, Host Interactions, and "

Read here: 👉 https://brnw.ch/21x2OUe

🔎 Norovirus remains the leading global cause of acute , driven by its low infectious dose, environmental persistence, and remarkable . In this comprehensive review, the authors synthesize current evidence on norovirus epidemiology, genomic organization, structural biology, , and mechanisms.

Key highlights include:
- Global patterns of genetic diversification and strain replacement, particularly within the GII.4 lineage
- The role of VP1 and VP2 in capsid architecture and antigenic specificity
- Critical insights into Histo-blood Group Antigens and host susceptibility
- Emerging directions for vaccine design and antiviral development

📜This review highlights the urgent need for integrated genomic surveillance and functional studies to advance broadly effective and strategies.

📢 We are pleased to highlight a recent contribution from Dr. Terenzio Cosio. Although he has been part of the editorial ...
07/05/2026

📢 We are pleased to highlight a recent contribution from Dr. Terenzio Cosio. Although he has been part of the editorial board for only a few months, he has already shown strong initiative and engagement with key topics in the field. 👏

On this occasion, we invite readers to explore his new publication, “ in ,” where he offers his perspective on how editorial decision-making shapes scientific discourse and publication standards in infectious disease research.

You can read the editorial here: 👇
https://brnw.ch/21x2gVE

📌 After reading it, we’d like to hear your thoughts. In your view, how do shape scientific communication, rigour, and the overall impact of research in infectious diseases?

🚨 New Paper Published | https://brnw.ch/21x20tZThe rapid growth of traditional medicines and health supplements (TMHS) r...
28/04/2026

🚨 New Paper Published | https://brnw.ch/21x20tZ

The rapid growth of traditional medicines and health supplements (TMHS) raises an important question: Are current manufacturing practices enough to ensure safety?📝

🏆Title: in Hard-Shell Capsule Traditional Medicines and in Malaysia: GMP Regulatory Oversight and Encapsulation Practices

🧑🏻‍⚕️Authors: Muhammad Amirul Amil, Jun Hao Koo, Xin Yun Yah, Norizzati Adila Salam and Muhammad Mawardi Zakaria

🏫Affilitation: Ministry of Health Malaysia

Key insights:
🦠 Higher recall risk – TMHS products showed a 4.73% recall rate, over 4× higher than (1.09%)
📊 Microbial contamination dominates – especially total count failures🏭 Process matters – increased automation and reduced manual handling help minimize contamination

👉 Read here: https://brnw.ch/21x20tY

22/04/2026
🎉 We are delighted to announce that   has been integrated into the Web of Science's Reviewer Recognition Service (RRS; f...
22/04/2026

🎉 We are delighted to announce that has been integrated into the Web of Science's Reviewer Recognition Service (RRS; formerly Publons)!

✨ This update means that scholars who conduct for Germs now have the option to receive recognition through their Web of Science Researcher Profile, helping them track and showcase their peer review contributions.

This initiative supports greater visibility and acknowledgment of the essential role reviewers play in scholarly publishing.

We are proud to contribute to strengthening and recognition in peer review, and to the global effort to properly value reviewer contributions.

A heartfelt thank you to our reviewer community! 🙌

Learn more:
https://brnw.ch/21x1P7x

🎉 Exciting news! Our journal has been accepted into the   database! 📚This milestone is an important step in increasing t...
03/04/2026

🎉 Exciting news! Our journal has been accepted into the database! 📚

This milestone is an important step in increasing the visibility and impact of our work.

Grateful to everyone involved in supporting and developing the journal —this achievement wouldn’t have been possible without you.

For more details about the journal’s indexing and abstracting, feel free to visit: 🌐 https://brnw.ch/21x1ioR

30/03/2026
🌟 On Day 3 of the conference, Prof. Dr. Oana Sandulescu, our Editor-in-Chief, delivered an insightful presentation on cr...
28/03/2026

🌟 On Day 3 of the conference, Prof. Dr. Oana Sandulescu, our Editor-in-Chief, delivered an insightful presentation on creative and supportive , with a focus on effectively communicating , structuring scientific work, and improving academic writing skills.

Her session aimed to support all participants in further developing their abstracts, encouraging those with outstanding research to expand their work into full-length articles. We are excited to invite you to submit your work to the dedicated to this conference:

👉 Link: https://brnw.ch/21x18wc
⏰ Deadline: 15 December 2026
👥 Guest Editors: Prof. Dr. Oana Sandulescu and Prof. Dr. Streinu-Cercel Anca

We hope this initiative will inspire you to take your research further and open new scientific conversations with us. We encourage you to take advantage of this opportunity and reach out for any support at germs@mdpi.com 📩

We would like to extend our appreciation to our Guest Editors for this project and their valuable contribution and support.

Wish you success in your future publications, and look forward to reading your work! ✨

Day 1 of the   and   7th Edition has ended and here is a preview! 🎉We are grateful to everyone who attended and took the...
27/03/2026

Day 1 of the and 7th Edition has ended and here is a preview! 🎉

We are grateful to everyone who attended and took the time to visit our booth. We hope you enjoyed the sessions and had a great experience throughout the day.

We would like to thank Prof. Dr. Scheau Cristian and Dr. Diana Elena Vulpe for their vision and initiative, and for taking the time to visit us. Stay tuned for what’s coming next in the following months, as we are preparing an exciting new project focused on orthopaedic infections. 🎊

And last but not least, we would like to recognise Dr. Anna-Karina Felder, who joined our team last year as one of our first Early Career Editorial Board Members. We are delighted to have her with us and wish her success in her future plans. 👏

Thank you all for being part of this journey!

Davidoaie Mălina

🌍 Viral Hepatitis: Key Updates & Clinical PerspectivesHow was the global fight against   evolving in 2024?Prof. Dr. Oana...
12/01/2026

🌍 Viral Hepatitis: Key Updates & Clinical Perspectives

How was the global fight against evolving in 2024?
Prof. Dr. Oana Săndulescu et al. summarise the latest advancements in prevention, diagnosis, treatment, and public‑health strategies.

What you need to know:
🧬 Progress across hepatitis A, B, C, D, and E with improved diagnostics and expanded antiviral access
💉 Updated insights on vaccination strategies, screening, and risk‑based prevention
🌍 Focus on equity, decentralised care, and global public health efforts

A timely resource for hepatologists, specialists, and health policy leaders shaping hepatitis care.

🔗 Read the perspective here: https://brnw.ch/21wZ0YH

Adresse

Basel
4052

Webseite

https://x.com/GERMS_MDPI, https://www.linkedin.com/company/germs-mdpi/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von GERMS MDPI erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Teilen